S. Michael Imperiale
Corporate Officer/Principal chez PARADIGM BIOPHARMACEUTICALS LIMITED
Postes actifs de S. Michael Imperiale
Sociétés | Poste | Début | Fin |
---|---|---|---|
PARADIGM BIOPHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/06/2020 | - |
Historique de carrière de S. Michael Imperiale
Anciens postes connus de S. Michael Imperiale
Sociétés | Poste | Début | Fin |
---|---|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Directeur Technique/Scientifique/R&D | 01/08/2007 | 01/01/2009 |
Nuvelo, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2006 | 01/01/2006 |
EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2004 | 01/01/2006 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/01/2004 | 01/01/2004 |
INTERMUNE INC | Directeur Technique/Scientifique/R&D | 17/06/2011 | - |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2009 | - |
SCRIPSAMERICA, INC. | Directeur/Membre du Conseil | 01/04/2011 | - |
Independent Dir/Board Member | 01/04/2011 | - |
Formation de S. Michael Imperiale
Hahnemann University | Doctorate Degree |
Villanova University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Australie | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 8 |
Consumer Services | 3 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
SCRIPSAMERICA, INC. | Distribution Services |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
EXELIXIS, INC. | Health Technology |
PARADIGM BIOPHARMACEUTICALS LIMITED | Health Technology |
Entreprise privées | 4 |
---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Nuvelo, Inc. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Bourse
- Insiders
- S. Michael Imperiale
- Expérience